SAMHD1
-
Official Full Name
SAM domain and HD domain 1 -
Overview
SAM domain and HD domain-containing protein 1 (SAMHD1) is a putative nuclease involved in innate immune response by acting as a negative regulator of the cell-intrinsic antiviral response. SAMHD1 may play a role in mediating proinflammatory responses to T -
Synonyms
SAMHD1;SAM domain and HD domain 1;SAM domain and HD domain-containing protein 1;AGS5;Aicardi Goutieres syndrome 5;HD domain containing 1;HDDC1;Mg11;monocyte protein 5;MOP 5;SBBI88;dendritic cell-derived IFNG-induced protein;DCIP;CHBL2;MOP-5
Recombinant Proteins
- Human
- Chicken
- Rhesus macaque
- Zebrafish
- Cynomolgus
- Mouse
- E.coli
- Mammalian Cells
- HEK293
- GST
- His
- Non
- DDK
- Myc
- Avi
- Fc
- Flag
Background
What is SAMHD1 Protein?
SAMHD1 is a protein that helps the immune system by breaking down dNTPs, which viruses like HIV-1 need to replicate. It mainly works in cells that don’t divide, like macrophages. This protein can be modified in several ways, which affects how well it can block viruses. Knowing more about SAMHD1 can lead to new ways to boost its action, potentially paving the path for treatments against viral infections.What is the Function of SAMHD1 Protein?
SAMHD1 protein serves as an important player in the immune system by breaking down dNTPs, which are essential for DNA synthesis in viruses. This action effectively prevents viruses, like HIV-1, from multiplying within cells that aren't actively dividing, such as macrophages. By controlling the dNTP levels, SAMHD1 limits virus replication, acting as a natural barrier against infections. Researchers are diving into how changes in SAMHD1 can either enhance or inhibit its function, aiming to leverage this understanding for creating new antiviral therapies.SAMHD1 Related Signaling Pathway
The SAMHD1-related signaling pathway is a critical component of the immune defense, focused on regulating dNTP levels to prevent viral replication. By breaking down these building blocks of DNA, SAMHD1 acts as a checkpoint against viruses like HIV-1, especially in cells like macrophages that don't usually divide. This pathway is influenced by various modifications to SAMHD1, including phosphorylation and acetylation, which either boost or curb its activity. Researchers are keen on understanding these regulatory mechanisms to explore potential antiviral therapies. By tapping into the SAMHD1 pathway, scientists aim to enhance the body's natural defenses against viral infections, offering hope for more effective treatments.
Fig1. Proposed molecular mechanisms and implications of SAMHD1-mediated inhibition of NF-κB activation and IFN-I induction. (Shuliang Chen, 2018)
SAMHD1 Related Diseases
SAMHD1-related diseases cover a diverse range, primarily affecting the immune and nervous systems. When SAMHD1 isn't functioning optimally, it can allow viruses like HIV-1 to proliferate in cells that typically act as viral barriers, such as macrophages. Beyond infections, alterations in SAMHD1 have been linked to autoimmune diseases and certain types of cancer, where immune regulation is crucial. For instance, imbalances in SAMHD1 activity can lead to unwanted inflammation or fail to suppress tumor growth. In neurodegenerative diseases, SAMHD1’s role in regulating cellular stress responses is crucial, as its dysfunction can contribute to neuronal damage. By studying these pathways, researchers aim to target SAMHD1 dysfunctions, possibly paving the way for new approaches in treatment strategies that address these complex diseases.Bioapplications of SAMHD1
SAMHD1 has promising bioapplications, particularly in the realm of antiviral and cancer therapies. Known for its ability to limit HIV-1 replication by breaking down dNTPs, its function can be harnessed to bolster the body's natural defenses against viruses. This ability makes SAMHD1 a potential target for enhancing antiviral treatments. Additionally, in cancer research, modulating SAMHD1 activity could influence tumor growth and survival, as its regulation affects cell division and death. By targeting SAMHD1, scientists hope to develop new therapies that can effectively tackle various cancers and viral infections. This dual application highlights SAMHD1’s potential in creating innovative medical treatments that leverage the body's own defense mechanisms.Case Study
Case Study 1: Qiang P. et al. Biol Direct. 2024
Endometrial cancer (EC) is tough to tackle due to its diverse nature and complex biology. SAMHD1, a key enzyme, is seen playing a part in the progression of various cancers, including EC. The research digs into how SAMHD1 affects EC by influencing the process where TRIM27 modifies PTEN through ubiquitination. By using bioinformatics and cell biology methods, we found that SAMHD1 alters PTEN's path via TRIM27, affecting vital pathways linked to EC development, hinting at how SAMHD1 might impact tumor growth and behavior in EC.-
Fig1. EMT-related molecule expression analysis post SAMHD1 overexpression using Western blot.
-
Fig2. IP to detect the interaction between SAMHD1 and PTEN.
Case Study 2: Bulnes-Ramos A. et al. mBio. 2024
SAMHD1 is an enzyme that helps prevent HIV-1 infection in cells like macrophages. This study finds that acetylation, especially at site K580, is essential for this protective role. Changes to K580 hinder its ability to block HIV-1. This acetylation increases as monocytes become macrophages, emphasizing its importance in fighting HIV-1. Understanding this could lead to new HIV-1 treatments.-
Fig3. Human 293T cells were co-transfected with a plasmid expressing HA-tagged WT SAMHD1.
-
Fig4. SAMHD1 dNTP hydrolysis.
Quality Guarantee
High Purity
-
Fig1. SDS-PAGE (SAMHD1-01H)
-
Fig2. SDS-PAGE (SAMHD1-2506H)
Involved Pathway
SAMHD1 involved in several pathways and played different roles in them. We selected most pathways SAMHD1 participated on our site, such as Cytokine Signaling in Immune system,Immune System,Interferon Signaling, which may be useful for your reference. Also, other proteins which involved in the same pathway with SAMHD1 were listed below. Creative BioMart supplied nearly all the proteins listed, you can search them on our site.
Pathway Name | Pathway Related Protein |
---|---|
Interferon alpha/beta signaling | IFI35,BST2,IRF6,IFIT2,ISG20,IFI27,IRF2,IFIT3,OASL,MX2 |
Interferon Signaling | EIF4G2,TRIM68,IFIT11,TRIM26,IFITM2,HLA-DQB2,TRIM14,IFIT14,BST2,TRIM29 |
Cytokine Signaling in Immune system | KPNA5,EIF4E,PAQR3B,LGALS9,UBE2L6,KLB,PRLRB,EDARADD,IFIT11,CSF2RA |
Immune System | POLR3H,LILRB4,IFITM2,DYNLL2,CLEC2G,AP1S1,CLEC2D,PELI3,PVRL2L,IRF9 |
-
Fig1. SAMHD1 regulates the molecular mechanism of PTEN ubiquitination mediated by TRIM27. (Ping Qiang, 2024)
-
Fig2. SAMHD1 impairs IFN-I induction through the MAVS, IKKε, and IRF7 signaling axis during viral infection. (Constanza E Espada, 2023)
Protein Function
SAMHD1 has several biochemical functions, for example, RNA binding,dGTP binding,dGTPase activity. Some of the functions are cooperated with other proteins, some of the functions could acted by SAMHD1 itself. We selected most functions SAMHD1 had, and list some proteins which have the same functions with SAMHD1. You can find most of the proteins on our site.
Function | Related Protein |
---|---|
RNA binding | CAPRIN2,DDX25,DAZ4,DHX34,FARSB,ELAVL4,RPL26,ZNF385B,RBM3,MBNL1 |
zinc ion binding | CA15B,ZNF257,MDM4,LIMA1,ADAM10,ESR2A,RARAB,USP16,PYGO2,ZKSCAN5 |
protein binding | CPNE1,NTRK3,PLRG1,CST2,CLASP1,FAM124A,CLDN18,SCARF1,WDR61,TAF6L |
nucleic acid binding | PLAGL2,PRDM7,ZBTB18,GPKOW,ZFP667,CNOT4B,SRSF6A,EWSR1A,ZNFL1,EAR4 |
Interacting Protein
SAMHD1 has direct interactions with proteins and molecules. Those interactions were detected by several methods such as yeast two hybrid, co-IP, pull-down and so on. We selected proteins and molecules interacted with SAMHD1 here. Most of them are supplied by our site. Hope this information will be useful for your research of SAMHD1.
DYSF;TIRAP;vpx;PHLDA3;1-phosphatidyl-1d-myo-inositol 3,5-bisphosphate;SF1;SMARCD2;SOGA1;PPP2R1A;AKAP12;STX3;SF1;PPP2R5E;HSF5;LRRK2;GPATCH4;RSBN1L
Resources
Related Services
Related Products
References
- Chauveau, L; Puigdomenech, I; et al. HIV-2 infects resting CD4+T cells but not monocyte-derived dendritic cells. RETROVIROLOGY 12:-(2015).
- Riveira-Munoz, E; Ruiz, A; et al. Increased expression of SAMHD1 in a subset of HIV-1 elite controllers. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 69:3057-3060(2014).